In addition to studying other EGFR targets for HNSCC treatment, targets such as programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) could be of interest. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.